Fuzhou General Hospital of Nanjing Military Area Command Trials

Fuzhou General Hospital of Nanjing Military Area Command	Welcome, Profile Billing Logout

Fuzhou General Hospital of Nanjing Military Area Command

Welcome, Profile Billing Logout

1 Trial

1 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Xi, Chen

NCT04088110: Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Not yet recruiting

RoW

Pyrotinib, Study drug, Trastuzumab, Herceptin®, Aromatase Inhibitors, anastrozole, letrozole or exemestane

Fuzhou General Hospital

Breast Cancer Female, HER2-positive Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Breast Cancer, Breast Diseases, Hormone Receptor Positive Tumor

11/21

11/23